GWM
BIO icon

Geneos Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Geneos Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
447
-1
-0.2% -$284 ﹤0.01% 1132
2026
Q1 		$125K Sell
448
-35
-7% -$10.1K ﹤0.01% 1107
2025
Q4 		$146K Buy
483
+467
+2,919% +$146K ﹤0.01% 1035
2025
Q3 		$4.49K Sell
16
-126
-89% -$34.3K ﹤0.01% 2163
2025
Q2 		$34.3K Buy
142
+76
+115% +$18K ﹤0.01% 1765
2025
Q1 		$16.1K Buy
66
+20
+43% +$6.02K ﹤0.01% 2048
2024
Q4 		$15.1K Buy
46
+3
+7% +$1.02K ﹤0.01% 1862
2024
Q3 		$14.4K Buy
+43
New +$13.7K ﹤0.01% 1686
2022
Q1 		– Sell
-3
Closed -$2K – 2762
2021
Q4 		$2K Sell
3
-34
-92% -$25.4K ﹤0.01% 2562
2021
Q3 		$27K Sell
37
-10
-21% -$7.49K ﹤0.01% 1765
2021
Q2 		$31K Buy
47
+10
+27% +$6.09K ﹤0.01% 1696
2021
Q1 		$23K Hold
37
– – ﹤0.01% 1993
2020
Q4 		$21K Buy
37
+34
+1,133% +$19.4K ﹤0.01% 1864
2020
Q3 		$1K Hold
3
– – ﹤0.01% 2489
2020
Q2 		$1K Buy
+3
New +$1.32K ﹤0.01% 2425
2020
Q1 		– Sell
-3
Closed -$1K – 2483
2019
Q4 		$1K Hold
3
– – ﹤0.01% 2435
2019
Q3 		$1K Buy
+3
New +$979 ﹤0.01% 2367

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geneos Wealth Management's BIO Position: Q2 2026 in Review

Geneos Wealth Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.22% in Q2 2026, selling an estimated $284 and leaving 447 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Geneos Wealth Management first reported a position in BIO in Q3 2019 and has held it in 17 quarters since. The position peaked at $146K in Q4 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Geneos Wealth Management held 447 shares of Bio-Rad Laboratories Class A worth $131K as of Q2 2026.
  • Geneos Wealth Management sold 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1132 holding.
  • Geneos Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and has held it in 17 quarters since.
  • Geneos Wealth Management's Bio-Rad Laboratories Class A position peaked at $146K in Q4 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.